Cargando…

Evaluation and Management of Wolff-Parkinson-White in Athletes

CONTEXT: Wolff-Parkinson-White (WPW) is a cardiac conduction system disorder characterized by abnormal accessory conduction pathways between the atria and the ventricles. Symptomatic patients classically present with palpitations, presyncope, or syncope that results from supraventricular tachycardia...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Ashwin L., Salerno, Jack C., Asif, Irfan M., Drezner, Jonathan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065555/
https://www.ncbi.nlm.nih.gov/pubmed/24982705
http://dx.doi.org/10.1177/1941738113509059
_version_ 1782322105190187008
author Rao, Ashwin L.
Salerno, Jack C.
Asif, Irfan M.
Drezner, Jonathan A.
author_facet Rao, Ashwin L.
Salerno, Jack C.
Asif, Irfan M.
Drezner, Jonathan A.
author_sort Rao, Ashwin L.
collection PubMed
description CONTEXT: Wolff-Parkinson-White (WPW) is a cardiac conduction system disorder characterized by abnormal accessory conduction pathways between the atria and the ventricles. Symptomatic patients classically present with palpitations, presyncope, or syncope that results from supraventricular tachycardia. While rare, sudden cardiac death may be the first manifestation of underlying disease and occurs more frequently in exercising individuals. EVIDENCE ACQUISITION: Medline and PubMed databases were evaluated through 2012, with the following keywords: WPW, Wolff-Parkinson-White, pre-excitation, sudden cardiac death, risk stratification, and athletes. Selected articles identified through the primary search, along with relevant references from those articles, were reviewed for pertinent clinical information regarding the identification, evaluation, risk stratification, and management of WPW as they pertained to the care of athletes. STUDY DESIGN: Systematic review. LEVEL OF EVIDENCE: Level 1. RESULTS: Diagnosis of WPW is confirmed by characteristic electrocardiogram changes, which include a delta wave, short PR interval, and widened QRS complex. Utilization of the electrocardiogram as part of the preparticipation physical evaluation may allow for early identification of asymptomatic individuals with a WPW pattern. Risk stratification techniques identify individuals at risk for malignant arrhythmias who may be candidates for curative therapy through transcatheter ablation. CONCLUSION: WPW accounts for at least 1% of sudden death in athletes and has a prevalence of at least 1 to 4.5 per 1000 children and adults. The risk of lethal arrhythmia appears to be higher in asymptomatic children than in adults, and sudden cardiac death is often the sentinel event. The athlete with WPW should be evaluated for symptoms and the presence of intermittent or persistent pre-excitation, which dictates further consultation, treatment, and monitoring strategies as well as return to play.
format Online
Article
Text
id pubmed-4065555
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-40655552015-07-01 Evaluation and Management of Wolff-Parkinson-White in Athletes Rao, Ashwin L. Salerno, Jack C. Asif, Irfan M. Drezner, Jonathan A. Sports Health Primary Care CONTEXT: Wolff-Parkinson-White (WPW) is a cardiac conduction system disorder characterized by abnormal accessory conduction pathways between the atria and the ventricles. Symptomatic patients classically present with palpitations, presyncope, or syncope that results from supraventricular tachycardia. While rare, sudden cardiac death may be the first manifestation of underlying disease and occurs more frequently in exercising individuals. EVIDENCE ACQUISITION: Medline and PubMed databases were evaluated through 2012, with the following keywords: WPW, Wolff-Parkinson-White, pre-excitation, sudden cardiac death, risk stratification, and athletes. Selected articles identified through the primary search, along with relevant references from those articles, were reviewed for pertinent clinical information regarding the identification, evaluation, risk stratification, and management of WPW as they pertained to the care of athletes. STUDY DESIGN: Systematic review. LEVEL OF EVIDENCE: Level 1. RESULTS: Diagnosis of WPW is confirmed by characteristic electrocardiogram changes, which include a delta wave, short PR interval, and widened QRS complex. Utilization of the electrocardiogram as part of the preparticipation physical evaluation may allow for early identification of asymptomatic individuals with a WPW pattern. Risk stratification techniques identify individuals at risk for malignant arrhythmias who may be candidates for curative therapy through transcatheter ablation. CONCLUSION: WPW accounts for at least 1% of sudden death in athletes and has a prevalence of at least 1 to 4.5 per 1000 children and adults. The risk of lethal arrhythmia appears to be higher in asymptomatic children than in adults, and sudden cardiac death is often the sentinel event. The athlete with WPW should be evaluated for symptoms and the presence of intermittent or persistent pre-excitation, which dictates further consultation, treatment, and monitoring strategies as well as return to play. SAGE Publications 2014-07 /pmc/articles/PMC4065555/ /pubmed/24982705 http://dx.doi.org/10.1177/1941738113509059 Text en © 2013 The Author(s)
spellingShingle Primary Care
Rao, Ashwin L.
Salerno, Jack C.
Asif, Irfan M.
Drezner, Jonathan A.
Evaluation and Management of Wolff-Parkinson-White in Athletes
title Evaluation and Management of Wolff-Parkinson-White in Athletes
title_full Evaluation and Management of Wolff-Parkinson-White in Athletes
title_fullStr Evaluation and Management of Wolff-Parkinson-White in Athletes
title_full_unstemmed Evaluation and Management of Wolff-Parkinson-White in Athletes
title_short Evaluation and Management of Wolff-Parkinson-White in Athletes
title_sort evaluation and management of wolff-parkinson-white in athletes
topic Primary Care
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065555/
https://www.ncbi.nlm.nih.gov/pubmed/24982705
http://dx.doi.org/10.1177/1941738113509059
work_keys_str_mv AT raoashwinl evaluationandmanagementofwolffparkinsonwhiteinathletes
AT salernojackc evaluationandmanagementofwolffparkinsonwhiteinathletes
AT asifirfanm evaluationandmanagementofwolffparkinsonwhiteinathletes
AT dreznerjonathana evaluationandmanagementofwolffparkinsonwhiteinathletes